Estimate Recalculated Jun 5, 2025 08:43PM EST
Braden Michael Leonard has an estimated net worth of $22.3 Million. This is based on reported shares across multiple companies, which include IMARA Inc., BUILD A BEAR WORKSHOP INC, Gemini Therapeutics, Inc. /DE, ProPhase Labs, Inc., ASTROTECH Corp, RETRACTABLE TECHNOLOGIES INC, Satsuma Pharmaceuticals, Inc., Metacrine, Inc., Orchids Paper Products CO /DE, Aclaris Therapeutics, Inc., Cyteir Therapeutics, Inc., Tectonic Therapeutic, Inc., Reneo Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., AN2 Therapeutics, Inc., and Talis Biomedical Corp.
Braden Michael Leonard's CIK is 0001373603
2011 was Braden Michael Leonard's most active year for acquiring shares with 2 total transactions. Braden Michael Leonard's most active month to acquire stocks was the month of April. 2022 was Braden Michael Leonard's most active year for disposing of shares, totalling 6 transactions. Braden Michael Leonard's most active month to dispose stocks was the month of November. 2022 saw Braden Michael Leonard paying a total of $181,815.00 for 205,000 shares, this is the most they've acquired in one year. In 2022 Braden Michael Leonard cashed out on 112,500 shares for a total of $411,625.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!